Malaysia Registers HIV Combination Treatment - CodeBlue


7/7/2022 12:00:00 AM3 years 7 months ago
by CodeBlue

The NPRA approved TELDY tablets, the first dolutegravir-based combination treatment registered in Malaysia for HIV, based on a voluntary licensing agreement between MPP and ViiV Healthcare.

KUALA LUMPUR, July 7 The National Pharmaceutical Regulatory Agency (NPRA) today issued conditional approval for an oral combination medication as the current standard of care treatment for HIV. Heal… [+1641 chars]

full article...